Trial Profile
A retrospective study to evaluate the efficacy and safety of the bendamustine-rituximab treatment in patients with follicular lymphoma previously exposed to rituximab
Status:
Completed
Phase of Trial:
Clinical Phase Unknown
Latest Information Update: 21 Jul 2017
Price :
$35
*
At a glance
- Drugs Bendamustine (Primary) ; Rituximab (Primary)
- Indications Follicular lymphoma
- Focus Expanded access; Therapeutic Use
- 21 Jul 2017 New trial record
- 25 Jun 2017 Results presented at the 22nd Congress of the European Haematology Association